These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9033488)

  • 1. Vancomycin-dependent enterococcus.
    Rossney AS; McConkey SJ; Keane CT
    Lancet; 1997 Feb; 349(9049):430. PubMed ID: 9033488
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin-dependent enterococcus.
    Wilks M
    Lancet; 1997 Feb; 349(9049):429. PubMed ID: 9033486
    [No Abstract]   [Full Text] [Related]  

  • 3. Occurrence of vancomycin-resistant enterococci in relation to the administration of glycopeptide antibiotics.
    Kolár M; Vágnerová I; Látal T; Kohnová I
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():69-71. PubMed ID: 10743728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-dependent Enterococcus.
    Swann RA; Bhattacharya S
    Indian J Med Microbiol; 2011; 29(1):71-2. PubMed ID: 21304202
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bacteremia caused by Enterococcus gallinarum with a high level of glycopeptide resistance: 1st documented cases in Argentina].
    Togneri A; Lopardo H; Corso A
    Rev Argent Microbiol; 2003; 35(2):96-9. PubMed ID: 12920991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enterococcal resistance to glycopeptide antibiotics].
    Cercendado Mansilla E
    Rev Clin Esp; 1995 Oct; 195 Suppl 4():22-7. PubMed ID: 9441312
    [No Abstract]   [Full Text] [Related]  

  • 7. Partial teicoplanin dependence in a vancomycin-dependent Enterococcus faecium isolated from an oncology patient 1 month after cessation of teicoplanin therapy, Austria 2007.
    Huhulescu S; Schmid D; Mayer B; Stadlbauer S; Wewalka G; Allerberger F; Dworzak M
    Int J Antimicrob Agents; 2008 Jan; 31(1):86-8. PubMed ID: 18006277
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation and characterization of the first vancomycin-dependent Enterococcus from India.
    Banerjee T; Anupurba S
    Indian J Med Microbiol; 2013; 31(1):91-2. PubMed ID: 23508442
    [No Abstract]   [Full Text] [Related]  

  • 9. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
    Lee JG; Sagui C; Roland C
    J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci.
    van Den Braak N; Goessens W; van Belkum A; Verbrugh HA; Endtz HP
    J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vancomycin resistance among strains of Enterococcus faecium].
    Sacha P; Wieczorek P; Jakoniuk P
    Przegl Lek; 2008; 65(5):229-32. PubMed ID: 18853647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug resistance of 100 clinical strains of Enterococcus spp].
    Sawicka-Grzelak A; Rokosz A; Luczak M
    Med Dosw Mikrobiol; 1999; 51(3-4):239-47. PubMed ID: 10803253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial resistance of enterococci in Turkey.
    Kaçmaz B; Aksoy A
    Int J Antimicrob Agents; 2005 Jun; 25(6):535-8. PubMed ID: 15908184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative microbiological and pharmacokinetic activity of vancomycin and teicoplanin].
    Cohen R; Barre J; Varon E
    Pathol Biol (Paris); 1992 Oct; 40(8):831-44. PubMed ID: 1484744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new molecular system for simultaneous identification of four Enterococcus species and their glycopeptide resistance genotypes.
    Eigner U; Fahr A; Weizenegger M; Witte W
    J Clin Microbiol; 2005 Jun; 43(6):2920-2. PubMed ID: 15956419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of high-level vancomycin resistance in enterococci isolated from meat-processing facilities.
    Bodnaruk PW; Krakar PJ; Tompkin RB
    Emerg Infect Dis; 2001; 7(6):1030-1. PubMed ID: 11747735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin-dependent enterococci: curious phenomenon or serious threat?
    Stewart B; Hall L; Duke B; Ball D
    J Antimicrob Chemother; 1997 Nov; 40(5):734-5. PubMed ID: 9421327
    [No Abstract]   [Full Text] [Related]  

  • 20. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
    Babalola CP; Patel KB; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.